Page last updated: 2024-08-23

fludrocortisone and Cholangiocarcinoma

fludrocortisone has been researched along with Cholangiocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alsma, J; Benner, BJM; Feelders, RA	1

Other Studies

1 other study(ies) available for fludrocortisone and Cholangiocarcinoma

Article	Year
Hyponatraemia and hyperpigmentation in primary adrenal insufficiency. BMJ case reports, 2019, Mar-07, Volume: 12, Issue:3 Topics: Addison Disease; Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Cholangiocarcinoma; Diagnosis, Differential; Fatal Outcome; Female; Fludrocortisone; Humans; Hydrocortisone; Hyperpigmentation; Hyponatremia; Inappropriate ADH Syndrome; Middle Aged; Paraneoplastic Syndromes	2019

Article

Year

Hyponatraemia and hyperpigmentation in primary adrenal insufficiency.

BMJ case reports, 2019, Mar-07, Volume: 12, Issue:3

Topics: Addison Disease; Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Cholangiocarcinoma; Diagnosis, Differential; Fatal Outcome; Female; Fludrocortisone; Humans; Hydrocortisone; Hyperpigmentation; Hyponatremia; Inappropriate ADH Syndrome; Middle Aged; Paraneoplastic Syndromes

2019